India's pharma sector faces a potential challenge. The US considers high tariffs on drug imports. This could hurt Indian companies' profits and competitiveness. It might also raise medicine prices in America. India relies heavily on the US for pharma exports. Companies may need to explore new markets like Europe and Southeast Asia. The news impacted Indian stock markets.